Mycobacteria tuberculosis peritonitis associated with etanercept therapy [5]

Clinical and Experimental Rheumatology

Volumn 21, Issue 4, 2003, Pages 526-

  Manadan, Augustine M ^a   Block, J A ^a   Sequeira, W ^a,b  

^a RUSH MEDICAL COLLEGE   (United States)

^b Jr Hospital of Cook County   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADALIMUMAB; CYTOKINE RECEPTOR; ETANERCEPT; INFLIXIMAB; ISONIAZID; METHOTREXATE; MONOCLONAL ANTIBODY; RIFAMPICIN; TUMOR NECROSIS FACTOR ALPHA RECEPTOR;

ADULT; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; DIARRHEA; DISEASE SEVERITY; EPIGASTRIC PAIN; FEMALE; FEVER; HUMAN; LABORATORY TEST; LAPAROTOMY; LETTER; MYCOBACTERIUM TUBERCULOSIS; NAUSEA; PHYSICAL EXAMINATION; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; THORAX RADIOGRAPHY; TUBERCULOUS PERITONITIS; VOMITING;

ADULT; ANTITUBERCULAR AGENTS; ARTHRITIS, JUVENILE RHEUMATOID; BIOPSY, NEEDLE; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOCOMPROMISED HOST; IMMUNOGLOBULIN G; IMMUNOHISTOCHEMISTRY; MYCOBACTERIUM TUBERCULOSIS; PERITONITIS; RECEPTORS, TUMOR NECROSIS FACTOR; RISK ASSESSMENT; TREATMENT OUTCOME; TUBERCULOSIS, GASTROINTESTINAL;

EID: 0042198781     PISSN: 0392856X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Letter

References (9)

1. CASE J: Old and new drugs used in rheumatoid arthritis: a historical perspective. Am J Therapeutics 2001; 8: 163-79.
2. MORELAND LW, SCHIFF MH, BAUMGARTNER SW: Etanercept therapy in RA: A randomized controlled trial. Ann Intern Med 1999;130:478.
3. FLYNN JL, GOLDSTEIN MM, CHAN J et al.: Tumor necrosis factor-α is required in the protective immune response against Mycobacterium tuberculosis in mice. Immunity 1995; 2: 561-72.
4. EHLERS S, BENINI J, KUTSCH S, ENDRES R, RIETSCHEL ET, PFEFFER K: Fatal granuloma necrosis without exacerbated mycobacterial growth in TNF receptor p55 gene-deficient mice intravenously infected with Mycobacterium avium. Infect Immun 1999; 67: 3571-9.
5. KINDLER VL, SAPPINO AP, GRAU E, PIGUET PF, VASALLI P: The inducing role of TNF in the development of bactericidal. Granulomas during BCG infection. Cell 1989; 56: 731-40.
6. KEANE J, GERSHON S, WISE RP et al.: Tuberculosis associated with Infliximab a tumor necrosis factor-α neutralizing agent. N Engl J Med 2001; 345 (15).
7. HOLMAN J, SABATH DF, VIVEASH D, BURGE DJ, GARRISON L, GARDINER M: Tuberculosis reports with etanercept therapy. (EULAR abstract). Ann Rheu Dis 2002; 61: FR10024.
8. MANADAN AM, MOHAN AK, COTE TR, SIEGEL JN, SEQUIERA W, BLOCK JA: Arthritis Rheum 2002; 46 (Suppl.): Ab. 356, pg. S166.
9. KENNEDY, DL, GOLDMAN SA, LILLIE RB: Spontaneous reporting in the United States. In Pharmcoepidemiology, 3rd ed., 2000: 10.